ProKidney (PROK) Revenue & Revenue Breakdown
ProKidney Revenue Highlights
Latest Revenue (Y)
$893.00K
Latest Revenue (Q)
$226.00K
ProKidney Revenue by Period
ProKidney Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $893.00K | 1075.00% |
| 2024-12-31 | $76.00K | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
ProKidney generated $893.00K in revenue during NA 2025, up 1075.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
ProKidney Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $226.00K | 0.44% |
| 2025-12-31 | $225.00K | 3.69% |
| 2025-09-30 | $217.00K | -1.81% |
| 2025-06-30 | $221.00K | -3.91% |
| 2025-03-31 | $230.00K | 202.63% |
| 2024-12-31 | $76.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | - |
ProKidney generated $226.00K in revenue during Q1 2026, up 0.44% compared to the previous quarter, and up 297.37% compared to the same period a year ago.
ProKidney Revenue Breakdown
ProKidney Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 |
|---|---|---|
| Reportable Segment | $221.00K | $230.00K |
Latest
ProKidney's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Reportable Segment (100.00%).
ProKidney Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KURA | Kura Oncology | $67.48M | $18.27M |
| TNGX | Tango Therapeutics | $62.38M | - |
| SEPN | Septerna | $45.95M | $26.52M |
| EYPT | EyePoint Pharmaceuticals | $31.37M | $696.00K |
| NBTX | Nanobiotix | $30.06M | $30.06M |
| PRME | Prime Medicine | $4.63M | - |
| PROK | ProKidney | $893.00K | $226.00K |
| RZLT | Rezolute | - | - |
| SVRA | Savara | - | - |
| BCAX | Bicara Therapeutics | - | - |
| TYRA | Tyra Biosciences | - | - |